2
Views
5
CrossRef citations to date
0
Altmetric
Cell Growth and Development

A Viral Long Terminal Repeat Expressed in CD4+CD8+ Precursors Is Downregulated in Mature Peripheral CD4-CD8+ or CD4+CD8- T Cells

, , , , , & show all
Pages 3522-3530 | Received 24 Jul 1991, Accepted 21 May 1992, Published online: 01 Apr 2023

REFERENCES

  • Acha-Orbea, H., A. N. Shakhov, L. Scarpellino, E. Kolb, V. Muller, A. Vessaz-Shaw, R. Fuchs, K. Blochlinger, P. Rollini, J. Billotte, M. Sarafidou, H. R. MacDonald, and H. Diggelmann. 1991. Clonal deletion of VB14-bearing T cells in mice transgenic for mammary tumour virus. Nature (London) 350:207–211.
  • Adams, J. M., A. W. Harris, C. A. Pinkert, L. M. Corcoran, W. S. Alexander, S. Cory, R. D. Palmiter, and R. L. Brinster. 1985. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature (London) 318:533–538.
  • Alexander, W. S., J. W. Schrader, and J. M. Adams. 1987. Expression of the c-myc oncogene under control of an immunoglobulin enhancer in Eu-myc transgenic mice. Mol. Cell. Biol. 7:1436–1444.
  • Alt, F. N., S. Rosenberg, S. Lewis, E. Thomas, and D. Baltimore. 1981. Organization and reorganization of immunoglobulin genes in A-MuLV-transformed cells: rearrangements of heavy but not light chain genes. Cell 27:381–390.
  • Ball, J. K., L. O. Arthur, and G. A. Dekaban. 1985. The involvement of a type-B retrovirus in the induction of thymic lymphomas. Virology 140:159–172.
  • Ball, J. K., and G. A. Dekaban. 1987. Characterization of early molecular biological events associated with thymic lymphoma induction following infection with a thymotropic type-B retrovirus. Virology 161:357–365.
  • Ball, J. K., H. Diggelmann, G. A. Dekaban, G. F. Grossi, R. Semmler, P. A. Waight, and R. F. Fletcher. 1988. Alterations in the U3 region of the long terminal repeat of an infectious thymotropic type B retrovirus. J. Virol. 62:2985–2993.
  • Bouchard, L., L. Lamarre, P. J. Tremblay, and P. Jolicoeur. 1989. Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene. Cell 57:931–936.
  • Breuer, M., R. Slebos, S. Verbeek, M. Van Lohuizen, E. Wientjens, and A. Berns. 1989. Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice. Nature (London) 340:61–63.
  • Caccia, N., M. Kronenberg, D. Saxe, R. Haars, G. A. P. Bruns, J. Governman, M. Malissen, H. Willard, Y. Yoshikai, M. Simon, L. Hood, and T. Mak. 1984. The T cell receptor B chain genes are located on chromosome 6 in mice and chromosome 7 in humans. Cell 37:1091–1099.
  • Celander, D., and W. A. Haseltine. 1984. Tissue-specific transcription preference as a determinant of cell tropism and leuke- mogenic potential of murine retroviruses. Nature (London) 312:159–162.
  • Chatis, P. A., C. A. Holland, J. W. Hartley, W. P. Rowe, and N. Hopkins. 1983. Role of the 3′ end of the genome in determining disease specificity of Friend and Moloney murine leukemia viruses. Proc. Natl. Acad. Sci. USA 80:4408–4411.
  • Chatis, P. A., C. A. Holland, J. E. Silver, T. N. Frederickson, N. Hopkins, and J. W. Hartley. 1984. A 3′ end fragment encompassing the transcriptional enhancers of nondefective Friend virus confers erythroleukemogenicity on Moloney leukemia virus. J. Virol. 52:248–254.
  • Chen, J., K. Neilson, and T. Van Dyke. 1989. Lymphotropic papovavirus early region is specifically regulated in transgenic mice and efficiently induces neoplasia. J. Virol. 63:2204–2214.
  • Choi, Y., J. W. Kappler, and P. Marrack. 1991. A superantigen encoded in the open reading frame of the 3′ long terminal repeat of mouse mammary tumour virus. Nature (London) 350:203–207.
  • Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156–159.
  • Cory, S., O. Bernard, D. Bowtell, S. Schrader, and J. W. Schrader. 1987. Murine c-myc retroviruses alter the growth requirements of myeloid cell lines. Oncogene Res. 1:61–76.
  • Dalrymple, S. A., and K. L. Beemon. 1990. BK virus T antigens induce kidney carcinomas and thymoproliferative disorders in transgenic mice. J. Virol. 64:1182–1191.
  • Dekaban, G. A., and J. K. Ball. 1984. Integration of type B Retroviral DNA in virus-induced primary murine thymic lymphomas. J. Virol. 52:784–792.
  • DesGroseillers, L., and P. Jolicoeur. 1984. Mapping the viral sequences conferring leukemogenicity and disease specificity in Moloney and amphotropic murine leukemia viruses. J. Virol. 52:448–456.
  • DesGroseillers, L., E. Rassart, and P. Jolicoeur. 1983. Thymotropism of murine leukemia virus is conferred by its long terminal repeat. Proc. Natl. Acad. Sci. USA 80:4203–4207.
  • Feinberg, A. P., and B. Vogelstein. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6–13.
  • Fowlkes, B. J., and D. M. Pardoll. 1989. Molecular and cellular events of T cell development. Adv. Immunol. 44:207–264.
  • Grignani, F., L. Lombardi, G. Inghirami, L. Sternas, K. Cechova, and R. Dalla-Favera. 1990. Negative autoregulation of c-myc gene expression is inactivated in transformed cells. EMBO J. 9:3913–3922.
  • Hariharan, I. K., A. W. Harris, M. Crawford, H. Abud, E. Webb, S. Cory, and J. M. Adams. 1989. A bcr-v-abl oncogene induces lymphomas in transgenic mice. Mol. Cell. Biol. 9:2798–2805.
  • Hogan, B. F., F. Costantini, and E. Lacy. 1986. Manipulating the mouse embryo: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
  • Land, H., L. F. Parada, and R. A. Weinberg. 1983. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature (London) 304:596–602.
  • Leder, A., P. K. Pattengale, A. Kuo, T. A. Stewart, and P. Leder. 1986. Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development. Cell 45:485–495.
  • Leder, P., J. Battey, G. Lenoir, C. Moulding, W. Murphy, H. Potter, T. Stewart, and R. Taub. 1983. Translocations among antibody genes in human cancer. Science 222:765–778.
  • Lemay, G., and P. Jolicoeur. 1984. Rearrangement of a DNA sequence homologous to a cell-virus junction fragment in several Moloney murine leukemia virus-induced rat thymomas. Proc. Natl. Acad. Sci. USA 81:38–42.
  • Lewis, S., N. Rosenberg, F. Alt, and D. Baltimore. 1982. Continuing kappa-gene rearrangement in a cell line transformed by Abelson murine leukemia virus. Cell 30:807–816.
  • Maddon, P. J., A. G. Dalgleish, J. S. McDougal, P. R. Clapham, R. A. Weiss, and R. Axel. 1986. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333–348.
  • Mango, S. E., G. D. Schuler, M. E. R. Steele, and M. D. Cole. 1989. Germ-line c-myc is not down-regulated by loss or exclusion of activating factors in myc-induced macrophage tumors. Mol. Cell. Biol. 9:3482–3490.
  • Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
  • Melton, D. A., P. A. Kreig, M. R. Rebagliati, T. Maniatis, K. Zinn, and M. R. Green. 1984. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 12:7035–7056.
  • Moore, D. H., C. A. Long, A. B. Vaidya, J. B. Sheffield, A. S. Dion, and E. Y. Lasfargues. 1979. Mammary tumor viruses. Adv. Cancer Res. 29:347–418.
  • Mueller, R. E., J. K. Ball, and F. P. H. Chan. 1989. Characterization of cell markers in type B retroviral-induced thymic lymphomas. 1. Surface antigen phenotype and karyotype in developing and primary lymphomas. Leuk. Res. 13:553–559.
  • Mueller, R. E., J. K. Ball, and F. P. H. Chan. 1989. Characterization of cell markers in type B retroviral-induced thymic lymphomas. II. Surface antigen phenotype, karyotype and proviral integration pattern in cultured lymphoma cells and cloned lines. Leuk. Res. 13:561–571.
  • Penn, L. J. Z., M. W. Brooks, E. M. Laufer, and H. Land. 1990. Negative autoregulation of c-myc transcription. EMBO J. 9:1113–1121.
  • Potter, M., F. Mushinski, E. B. Mushinski, S. Brust, J. S. Wax, F. Wiener, M. Babonits, U. R. Rapp, and H. C. Morse III. 1987. Avian v-myc replaces chromosomal translocation in murine plasmacytomagenesis. Science 235:787–789.
  • Robey, E. A., B. J. Fowlkes, and D. M. Pardoll. 1990. Molecular mechanisms for lineage commitment in T cell development. Semin. Immunol. 2:25–34.
  • Roehm, N., L. Herron, J. Cambier, D. DiGuisto, K. Haskins, J. Kappler, and P. Marrack. 1984. The major histocompatibility complex-restricted antigen receptor on T cells: distribution on thymus and peripheral T cells. Cell 38:577–584.
  • Rosen, C. A., W. A. Haseltine, J. Lenz, R. Ruprecht, and M. W. Cloyd. 1985. Tissue selectivity of murine leukemia virus infection is determined by long terminal repeat sequences. J. Virol. 55:862–866.
  • Spanopoulou, E., A. Early, J. Elliott, N. Crispe, H. Ladyman, M. Ritter, S. Watt, F. Grosveld, and D. Kioussis. 1989. Complex lymphoid and epithelial thymic tumors in Thy 1-myc transgenic mice. Nature (London) 342:185–189.
  • Stewart, T. A., P. K. Pattengale, and P. Leder. 1984. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 38:627–637.
  • Van Lohuizen, M., M. Verbeek, P. Krimpenfort, J. Domen, C. Saris, T. Radaszkiewicz, and A. Berns. 1989. Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell 56:673–682.
  • Villemur, R., Y. Monczak, E. Rassart, C. Kozak, and P. Jolicoeur. 1987. Identification of a new common provirus integration site in Gross passage A murine leukemia virus-induced mouse thymoma DNA. Mol. Cell. Biol. 7:512–522.
  • Vogt, M., C. Haggblom, S. Swift, and M. Haas. 1985. Envelope gene and long terminal repeat determine the different biological properties of Rauscher, Friend, and Moloney mink cell focusinducing viruses. J. Virol. 55:184–192.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.